Agilent Technologies, Inc. $A Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 34,038,666 shares of the medical research company’s stock after buying an additional 40,821 shares during the quarter. Vanguard Group Inc. owned 0.12% of Agilent Technologies worth $4,368,863,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of A. Capital A Wealth Management LLC grew its position in Agilent Technologies by 10,600.0% in the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares in the last quarter. Davis Capital Management purchased a new position in shares of Agilent Technologies in the third quarter valued at $28,000. Physician Wealth Advisors Inc. grew its holdings in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares in the last quarter. State of Wyoming purchased a new stake in Agilent Technologies during the 2nd quarter worth $35,000. Finally, SJS Investment Consulting Inc. lifted its holdings in Agilent Technologies by 2,836.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after buying an additional 312 shares in the last quarter.

Agilent Technologies Price Performance

Shares of NYSE A opened at $123.75 on Wednesday. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $35.00 billion, a price-to-earnings ratio of 27.08, a price-to-earnings-growth ratio of 3.65 and a beta of 1.30. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27. The business has a 50 day simple moving average of $137.17 and a 200-day simple moving average of $135.68.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.32%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on A shares. HSBC started coverage on Agilent Technologies in a research note on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. Bank of America raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. upped their target price on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.